Lesabelimab (LDP) is an anti-CD274 monoclonal antibody of the immunoglobulin G1-kappa subclass. It targets CD274, an immune checkpoint ligand that suppresses antitumor immunity by engaging with the PDCD1 receptor [1] [2].
Purity:
95.00%
CAS Number:
[2475402-56-1]
Target:
PD-1/PD-L1
* VAT and and shipping costs not included. Errors and price changes excepted
